Following nature ' s rules, researchers develop new methods for treating degenerative neurological disease

Following nature's rules, researchers develop new methods for treating degenerative neurological disease The University of Arizona has licensed the new class of drugs designed to penetrate the blood-brain barrier to startup Teleport Pharmaceuticals. Paul Tumarkin Tuesday Tech Launch Arizonateleport-web-crop.jpg Robin Polt (right) coaches undergraduate student Hannah Kuo Feinberg as she works on a glycopeptide project in Polt ’s lab. Paul Tumarkin/Tech Launch ArizonaHealthScience and TechnologyCollege of Medicine - TucsonCollege of ScienceDeterminationExpertsExplorationTech Launch Arizona Media contact(s)Paul Tumarkin Tech Launch Arizonapault@tla.arizona.edu520-626-8770University of Arizona researchers have developed a new class of drugs that is able to cross the blood-brain barrier and could be used to treat degenerative neurological diseases and conditions." Francis Bacon said it best when he wrote, ' Nature, to be commanded, must be obeyed, ' " saidRobin Polt, co-inventor of the new drug technology and a professor in theDepartment of Chemistry and Biochemistryin the UArizonaCollege of Science. " We ' re taking nature ' s own tools and using them to design drugs. "Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. Brain disorders like Alzheimer ' s disease, Parkinson ' s disease, Huntington ' s disease, traumatic brain injury and stroke affect over 8 million people in the United States each year and h...
Source: The University of Arizona: Health - Category: Universities & Medical Training Authors: Source Type: research